Acquiring Company
Tilray Medical
Acquired Company
Zydus Lifesciences
Description
Assertio has announced the completion of its merger with Zydus Lifesciences. This strategic move marks a significant transition for Assertio in enhancing its market presence. The merger also involves changes related to Assertio's convertible senior notes. Both companies are committed to creating value in the healthcare sector.
Fundz sees it the moment Tilray Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Zydus Lifesciences?
Zydus Lifesciences was acquired by Tilray Medical, based in Seattle. The deal was reported on June 17, 2026. Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. Tilray Medical is publicly traded (TLRY) and operates in Other.
When did Tilray Medical acquire Zydus Lifesciences?
Tilray Medical's acquisition of Zydus Lifesciences was reported on June 17, 2026. Assertio has announced the completion of its merger with Zydus Lifesciences. This strategic move marks a significant transition for Assertio in enhancing its market presence. The merger also involves changes related to Assertio's convertible senior notes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Zydus Lifesciences do?
After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. It is privately held, operating in Health Care.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.